Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan and Iloprost in Pulmonary Arterial Hypertension
NCT01712997Phase 3Unknown
- Sponsor
- Air Force Medical University
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Air Force Medical University. Status: unknown.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01712997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712997.